Patients' perceptions of topical treatments of actinic keratosis

Journal of Dermatological Treatment

Volumn 25, Issue 5, 2014, Pages 375-379

  Esmann, Solveig ^a   Jemec, Gregor B E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Actinic keratosis; Efficiency; Interview; Pain; Patient perspectives; Topical treatment

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; DICLOFENAC; FLUOROURACIL; IMIQUIMOD;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CREAM; DIZZINESS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; FEMALE; FEVER; FLU LIKE SYNDROME; GEL; HUMAN; LEISURE; MALE; PERCEPTION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RISK FACTOR; SKIN PAIN; SKIN ULCER; SOCIAL BEHAVIOR; STRUCTURED INTERVIEW; TELEPHONE INTERVIEW; URTICARIA;

ADMINISTRATION, TOPICAL; AGED; AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; DICLOFENAC; FEMALE; FLUOROURACIL; GELS; HUMANS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PHOTOCHEMOTHERAPY; PRECANCEROUS CONDITIONS; SKIN CREAM;

EID: 84890357470     PISSN: 09546634     EISSN: 14711753     Source Type: Journal    
DOI: 10.3109/09546634.2012.757285     Document Type: Article

References (23)

1. Salasche SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:4-7
2. Shoimer I, Rosen N, Muhn C. Current management of actinic keratoses. Skin Therapy Lett. 2010;15:5-7
3. Berman B, Cohen DE, Amini S. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: Overview and investigational topical agents. Cutis. 2012;89:241-250
4. Ferrandiz L, Ruiz-de-Casas A, Trakatelli M, de VE, Ulrich M, Aquilina S, et al. Assessing physicians' preferences on skin cancer treatment in Europe. Br J Dermatol. 2012;167:29-35
5. Tran DT, Salmon R. Field treatment of facial and scalp actinic keratoses with photodynamic therapy: Survey of patient perceptions of treatment satisfaction and outcomes. Australas J Dermatol. 2011;52: 195-201
6. Hulka BS, Cassel JC, Kupper LL, Burdette JA. Communication, compliance, and concordance between physicians and patients with prescribed medications. Am J Public Health. 1976;66:847-853
7. Basak PY, Ozturk M, Baysal V. Assessment of information and education about topical corticosteroids in dermatology outpatient departments: Experience from Turkey. J Eur Acad Dermatol Venereol. 2003;17:652-658
8. Yentzer B, Hick J, Williams L, Inabinet R, Wilson R, Camacho FT, et al. Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses. Arch Dermatol. 2009;145:203-205
9. Stockfleth E, Zwingers T, Willers C. Recurrence rates and patient assessed outcomes of 0.5% 5-fluorouracil in combination with salicylic acid treating actinic keratoses. Eur J Dermatol. 2012;22:370-374
10. Ali SM, Brodell RT, Balkrishnan R, Feldman SR. Poor adherence to treatments: A fundamental principle of dermatology. Arch Dermatol. 2007;143:912-915
11. Lee IA, Maibach HI. Pharmionics in dermatology: A review of topical medication adherence. Am J Clin Dermatol. 2006;7:231-236
12. Martin GM. Impact of interval and combination therapies on the management of actinic keratosis: Review and clinical considerations. J Dermatolog Treat. 2011;22:288-297
13. Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B. Ingenol mebutate gel for actinic keratosis. N Engl J Med. 2012;366:1010-1019
14. Nelson CG, Spencer J, Nelson CG Jr. A single-arm, open-label efficacy and tolerability study of diclofenac sodium 3% gel for the treatment of actinic keratosis of the upper and lower lip. J Drugs Dermatol. 2007;6: 712-717
15. Tierney EP, Eide MJ, Jacobsen G, Ozog D. Photodynamic therapy for actinic keratoses: Survey of patient perceptions of treatment satisfaction and outcomes. J Cosmet Laser Ther. 2008;10:81-86
16. Smith SR, Morhenn VB, Piacquadio DJ. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp. J Drugs Dermatol. 2006;5:156-159
17. Yentzer B, Hick J, Williams L, Inabinet R, Wilson R, Camacho FT, et al. Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses. Arch Dermatol. 2009;145:203-205
18. Lee AD, Jorizzo JL. Optimizing management of actinic keratosis and photodamaged skin: Utilizing a stepwise approach. Cutis. 2009;84: 169-175
19. Szepietowski JC, Reich A. Stigmatisation in onychomycosis patients: A population-based study. Mycoses. 2009;52:343-349
20. Schmid-Ott G, Kunsebeck HW, Jecht E, Shimshoni R, Lazaroff I, Schallmayer S, et al. Stigmatization experience, coping and sense of coherence in vitiligo patients. J Eur Acad Dermatol Venereol. 2007;21: 456-461
21. Jorizzo JL, Carney PS, Ko WT, Robins P, Weinkle SH, Werschler WP. Matching patients with therapy. Cutis. 2004;74:5-8
22. Stockfleth E, Ferrandiz C, Grob JJ, Leigh I, Pehamberger H, Kerl H. Development of a treatment algorithm for actinic keratoses: A European Consensus. Eur J Dermatol. 2008;18:651-659
23. Esmann S, Jemec GB. Management of actinic keratosis patients: A qualitative study. J Dermatolog Treat. 2007;18:53-58